Home

sword Senate approve in re accutane new jersey supreme court Often spoken testimony Madison

Order Admitting To Practice Pro Hac Vice - Marie Woodbury
Order Admitting To Practice Pro Hac Vice - Marie Woodbury

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A-4760-14T1  A-0164-15T1 IN RE: ACCUTANE LITIGATION
SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A-4760-14T1 A-0164-15T1 IN RE: ACCUTANE LITIGATION

New Jersey Expert Admissibility Standard: “Reconciled” with Daubert
New Jersey Expert Admissibility Standard: “Reconciled” with Daubert

The New Jersey Supreme Court Has Adopted the Expert Admissibility FACTORS  AND Gatekeeping Function of the Trial Court's Enunciat
The New Jersey Supreme Court Has Adopted the Expert Admissibility FACTORS AND Gatekeeping Function of the Trial Court's Enunciat

2020 Thomson Reuters. No claim to original U.S. Government Works. 1 235 N.J.  229 Supreme Court of New Jersey. IN RE: ACCUTANE
2020 Thomson Reuters. No claim to original U.S. Government Works. 1 235 N.J. 229 Supreme Court of New Jersey. IN RE: ACCUTANE

A-25-17 In re: Accutane Litigation (079958)
A-25-17 In re: Accutane Litigation (079958)

A-4952-16T1 - IN RE: ACCUTANE LITIGATION (MCL-271, ATLANTIC COUNTY AND  STATEWIDE)
A-4952-16T1 - IN RE: ACCUTANE LITIGATION (MCL-271, ATLANTIC COUNTY AND STATEWIDE)

Untitled
Untitled

New Jersey Appellate Panel Reverses Trial Court's Detailed Exclusion of  Unreliable Expert Testimony - Life Science Matters
New Jersey Appellate Panel Reverses Trial Court's Detailed Exclusion of Unreliable Expert Testimony - Life Science Matters

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION SUPERIOR  COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A
NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A

Facing thousands of Accutane claims, Roche wins appeal of $18M jury verdict  | Fierce Pharma
Facing thousands of Accutane claims, Roche wins appeal of $18M jury verdict | Fierce Pharma

$25 Million Accutane Verdict Vacated On Appeal In New Jersey On Law Choice,  Limitations - Litigation Blog - Litigation - LexisNexis® Legal Newsroom
$25 Million Accutane Verdict Vacated On Appeal In New Jersey On Law Choice, Limitations - Litigation Blog - Litigation - LexisNexis® Legal Newsroom

In re Accutane Litigation, 234 N.J. 340 (N.J. 2018)
In re Accutane Litigation, 234 N.J. 340 (N.J. 2018)

NJ Supreme Court Issues Another Landmark Decision in In re Accutane, this  Time Regarding Choice-of-Law and the Presumption of Adequacy for  FDA-Approved Warnings | McCarter & English, LLP
NJ Supreme Court Issues Another Landmark Decision in In re Accutane, this Time Regarding Choice-of-Law and the Presumption of Adequacy for FDA-Approved Warnings | McCarter & English, LLP

Supreme Court Strengthens Standard for Use of Expert Testimony
Supreme Court Strengthens Standard for Use of Expert Testimony

Untitled
Untitled

New Addition to New Jersey Court Rules Impacts More Than Trial Practice -  Lewis Brisbois Bisgaard & Smith LLP
New Addition to New Jersey Court Rules Impacts More Than Trial Practice - Lewis Brisbois Bisgaard & Smith LLP

Accutane Lawsuit | When Should You Talk to a Lawyer?
Accutane Lawsuit | When Should You Talk to a Lawyer?

Supreme Court of New Jersey Archives - Government & Law Blog
Supreme Court of New Jersey Archives - Government & Law Blog

New Jersey Supreme Court Sets Higher Standards For Expert Opinions |  Respond Law
New Jersey Supreme Court Sets Higher Standards For Expert Opinions | Respond Law

Expert Evidence | New Jersey Civil Justice Institute
Expert Evidence | New Jersey Civil Justice Institute

Roche faces more than 2K Accutane liability cases as appeals panels reverse  rulings | Fierce Pharma
Roche faces more than 2K Accutane liability cases as appeals panels reverse rulings | Fierce Pharma

Court Axes Accutane Suits, Adopts 'Daubert' Standard for Expert Reports | New  Jersey Law Journal
Court Axes Accutane Suits, Adopts 'Daubert' Standard for Expert Reports | New Jersey Law Journal

ORDER TO DELETE submitted by Case Management Staff October 30, 2017 |  Trellis
ORDER TO DELETE submitted by Case Management Staff October 30, 2017 | Trellis

Untitled
Untitled

Johnson & Johnson Cites NJ Supreme Court's Accutane Decision in Talc Appeal  | New Jersey Law Journal
Johnson & Johnson Cites NJ Supreme Court's Accutane Decision in Talc Appeal | New Jersey Law Journal

Accutane Lawsuit Status – Injuries & Jury Verdicts
Accutane Lawsuit Status – Injuries & Jury Verdicts

Another Expert Exclusion Order Secured by Colleen Hennessey and Team in New  Jersey Accutane-IBD Litigation is Affirmed by the New Jersey Appellate  Division – Peabody & Arnold
Another Expert Exclusion Order Secured by Colleen Hennessey and Team in New Jersey Accutane-IBD Litigation is Affirmed by the New Jersey Appellate Division – Peabody & Arnold

Untitled
Untitled